Context Therapeutics Inc. Files 8-K
Ticker: CNTX · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1842952
| Field | Detail |
|---|---|
| Company | Context Therapeutics Inc. (CNTX) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, financial-statements
TL;DR
CTX is filing an 8-K with corporate updates and financial info.
AI Summary
Context Therapeutics Inc. filed an 8-K on June 2, 2025, reporting on other events and financial statements. The filing details the company's corporate structure, including its incorporation in Delaware and its fiscal year end of December 31. The company's principal executive offices are located at 2001 Market Street, Suite 3915, Unit #15, Philadelphia, PA 19103.
Why It Matters
This 8-K filing provides essential corporate information and updates for Context Therapeutics Inc., which is crucial for investors and stakeholders to understand the company's structure and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain significant new financial or operational information that would immediately impact risk.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's annual accounting period.)
- 001-40654 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Context Therapeutics Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 2001 Market Street, Suite 3915, Unit #15 (address) — Principal executive offices
- Philadelphia, Pennsylvania (location) — City and State of principal executive offices
- June 2, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report for Context Therapeutics Inc., detailing other events and including financial statements and exhibits.
When was this 8-K report filed?
The report was filed on June 2, 2025.
In which state is Context Therapeutics Inc. incorporated?
Context Therapeutics Inc. is incorporated in Delaware.
What is the address of Context Therapeutics Inc.'s principal executive offices?
The principal executive offices are located at 2001 Market Street, Suite 3915, Unit #15, Philadelphia, Pennsylvania 19103.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Context Therapeutics Inc. (CNTX).